当前位置: X-MOL 学术Pediatr. Blood Cancer › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Gadolinium is not necessary for surveillance MR imaging in children with chiasmatic-hypothalamic low-grade glioma
Pediatric Blood & Cancer ( IF 2.4 ) Pub Date : 2021-06-16 , DOI: 10.1002/pbc.29178
Fatema Malbari 1 , Murali M Chintagumpala 2 , Alexis C Wood 3 , Adam S Levy 4 , Jack M Su 2 , M Fatih Okcu 2 , Frank Y Lin 2 , Holly Lindsay 2 , Surya P Rednam 2 , Patricia A Baxter 2 , Arnold C Paulino 5 , Guillermo Aldave Orzaiz 6 , William E Whitehead 6 , Robert Dauser 6 , Nucharin Supakul 7 , Stephen F Kralik 8
Affiliation  

Patients with chiasmatic-hypothalamic low-grade glioma (CHLGG) have frequent MRIs with gadolinium-based contrast agents (GBCA) for disease monitoring. Cumulative gadolinium deposition in the brains of children is a potential concern. The purpose of this study is to evaluate whether MRI with GBCA is necessary for determining radiographic tumor progression in children with CHLGG.

中文翻译:

钆对于患有交叉下丘脑低级别胶质瘤的儿童的 MR 成像监测不是必需的

患有交叉下丘脑低级别胶质瘤 (CHLGG) 的患者经常使用基于钆的造影剂 (GBCA) 进行 MRI 以监测疾病。儿童大脑中的累积钆沉积是一个潜在的问题。本研究的目的是评估 GBCA 的 MRI 是否对于确定 CHLGG 儿童的影像学肿瘤进展是否必要。
更新日期:2021-08-23
down
wechat
bug